How to Adjust Inpatient Insulin Regimens
For most hospitalized patients with type 2 diabetes, use a basal-bolus regimen starting at 0.3-0.5 U/kg/day (split 50% basal, 50% prandial), but switch to a basal-plus approach (basal insulin 0.1-0.25 U/kg/day plus correctional insulin) for NPO patients, those with mild hyperglycemia (<200 mg/dL), or patients undergoing procedures to minimize hypoglycemia risk. 1
Initial Insulin Dosing Strategy
For Insulin-Naive or Low-Dose Patients
- Calculate total daily dose (TDD): 0.3-0.5 U/kg body weight 1
- Distribute as follows:
- 50% as basal insulin (given once or twice daily)
- 50% as rapid-acting prandial insulin (divided equally before three meals)
- Add correctional insulin on top of prandial doses
Use lower end (0.3 U/kg) for high-risk patients: age >65 years, renal failure, poor oral intake 1
For Patients on Home Insulin ≥0.6 U/kg/day
Reduce total daily dose by 20% upon admission to prevent hypoglycemia from decreased oral intake in the hospital 1
Regimen Selection Based on Clinical Context
Standard Eating Patients with Type 2 Diabetes
Use basal-bolus regimen - this approach reduces complications (wound infection, pneumonia, bacteremia, renal/respiratory failure) compared to sliding scale alone 1
NPO or Fasting Patients
Use basal-plus approach instead of full basal-bolus 1:
- Basal insulin: 0.1-0.25 U/kg/day
- Correctional rapid-acting insulin every 6 hours (if NPO) or before meals
- Critical pitfall: Never use sliding scale insulin alone in type 1 diabetes patients, even if NPO 1
The basal-plus approach carries 4-6 times lower hypoglycemia risk than basal-bolus (risk ratio 0.17-0.24 for blood glucose <70 mg/dL) 1. Research shows no difference in hypoglycemia rates when giving ≤50% versus >50% of home basal insulin in NPO patients, but hyperglycemia increases with lower doses 2.
Patients with Mild Hyperglycemia (<200 mg/dL)
Use basal-plus rather than full basal-bolus to avoid overtreatment 1
Non-Diabetic Patients with Stress Hyperglycemia
Sliding scale insulin alone is acceptable 1
- Add basal insulin only if unable to maintain glucose <180 mg/dL
Correction Factor (Supplemental Insulin) Dosing
For moderate hyperglycemia (140-260 mg/dL): Less aggressive correction is noninferior to intensive correction when basal-bolus is optimized 3
Practical approach:
- Correct for glucose >260 mg/dL in all patients
- For glucose 140-260 mg/dL, correction may be omitted if basal-bolus doses are adequate 3
- This reduces insulin administration burden without compromising glycemic control
Daily Adjustments
When to Increase Insulin
- Persistent hyperglycemia: Increase TDD by 10-20%
- Distribute increases: Adjust the insulin component corresponding to timing of hyperglycemia
- Fasting hyperglycemia → increase basal
- Post-meal hyperglycemia → increase prandial
- Both → increase proportionally
When to Decrease Insulin
Critical safety measure: If hypoglycemia occurs (glucose <70 mg/dL), 75% of patients have no dose adjustment made before the next insulin dose - this is a major preventable error 4
Mandatory actions after hypoglycemia:
- Reduce relevant insulin component by 20-30% immediately
- Fasting blood glucose <100 mg/dL predicts next-day hypoglycemia 4
- Most hypoglycemia with basal insulin occurs midnight-6 AM 4
Special Situations
Transitioning from IV Insulin Infusion
Calculate subcutaneous TDD from last 12 hours of infusion:
- Example: 1.5 U/hour × 12 hours = 18 U → TDD = 36 U/24 hours 1
- Split 50% basal, 50% prandial (if eating)
- Give first subcutaneous dose 2-4 hours before stopping infusion
Patients on Glucocorticoids
Use NPH insulin for once or twice-daily steroids (peaks 4-6 hours after administration, matching steroid effect) 4
- Add to existing basal-bolus regimen
- May need 40-60% increase in prandial and correctional insulin for high-dose steroids 4
Enteral/Parenteral Nutrition
Calculate nutritional insulin: 1 unit per 10-15 g carbohydrate in formula 4
- Give NPH every 8-12 hours to cover continuous feeds
- Type 1 diabetes patients must continue basal insulin even if feeds stopped
- Start dextrose infusion immediately if nutrition interrupted 4
What NOT to Do
Avoid premixed insulin (70/30) - unacceptably high hypoglycemia rates in hospital 1
Avoid sliding scale insulin alone in patients with established diabetes - associated with worse glycemic control and more complications 1
Avoid tight glycemic targets (80-110 mg/dL) - substantially increases hypoglycemia risk without mortality benefit 1
Target Blood Glucose
Aim for 70-180 mg/dL for most non-critically ill patients 4
This evidence-based algorithmic approach prioritizes patient safety by minimizing life-threatening hypoglycemia while maintaining adequate glycemic control to reduce infectious and metabolic complications.